title: (Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: from antioxidants to kinase inhibitors.
authors.forename: Michael
authors.initials: M
authors.lastname: Maes
authors.forename: Brian
authors.initials: B
authors.lastname: Leonard
authors.forename: Alberto
authors.initials: A
authors.lastname: Fernandez
authors.forename: Marta
authors.initials: M
authors.lastname: Kubera
authors.forename: Gabriel
authors.initials: G
authors.lastname: Nowak
authors.forename: Rob
authors.initials: R
authors.lastname: Veerhuis
authors.forename: Ann
authors.initials: A
authors.lastname: Gardner
authors.forename: Piaynuj
authors.initials: P
authors.lastname: Ruckoanich
authors.forename: Michel
authors.initials: M
authors.lastname: Geffard
authors.forename: Carlo
authors.initials: C
authors.lastname: Altamura
authors.forename: Piotr
authors.initials: P
authors.lastname: Galecki
authors.forename: Michael
authors.initials: M
authors.lastname: Berk
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use*; D000975:Antioxidants / Q000627:therapeutic use*; D003863:Depression / Q000188:drug therapy* / Q000276:immunology / Q000378:metabolism; D055808:Drug Discovery; D006801:Humans; D007249:Inflammation / Q000188:drug therapy* / Q000503:physiopathology; D058990:Molecular Targeted Therapy; D015213:Neuroimmunomodulation / Q000187:drug effects / Q000502:physiology; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*
chemical_list: D000893:Anti-Inflammatory Agents; D000928:Antidepressive Agents; D000975:Antioxidants; D047428:Protein Kinase Inhibitors